X4 Pharmaceuticals

With Rare Resolve, X4 is delivering progress for patients by developing and commercializing innovative therapies for those with rare diseases of the immune system and significant unmet needs.

SCNIR

The Severe Chronic Neutropenia International Registry (SCNIR or Registry) is a global organization dedicated to finding the causes, consequences, and best treatments for severe chronic neutropenia (SCN).

Probably Genetic’s no-cost genetic testing program for primary immunodeficiencies is patient-initiated and includes genetic counseling to explain any questions or findings.